Chop Deficiency Protects Mice against Bleomycin-induced Pulmonary Fibrosis by Attenuating M2 Macroph

来源 :2016中华医学会呼吸病学年会暨第十七次全国呼吸病学学术会议 | 被引量 : 0次 | 上传用户:klzvms1
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  目的 Idiopathic pulmonary fibrosis (IPF) is a severe health problem worldwide and has one of the poorest prognoses.C/EBP homologous protein (Chop), one of the endoplasmic reticulum (ER) stress markers, has been found with altered expression in patients with IPF, while its exact role in IPF pathoetiology is yet to be fully addressed.方法 Studies were conducted in IPF patients and Chop-/- mice to dissect the role of Chop and ER stress in pulmonary fibrosis pathogenesis.Bleomycin (BLM) was employed to induce mice with onset of pulmonary fibrosis to address the impact of Chop deficiency on the development of pulmonary fibrosis.The effect of Chop deficiency on macrophage polarization and related signaling pathways were next investigated to demonstrate the underlying mechanisms.结果 IPF patients and mice with onset BLM-induced pulmonary fibrosis experienced altered Chop expression and ER stress.In particular, Chop was predominantly overexpressed by the infiltrated macrophages.As a result, the loss of Chop protected mice against BLM-induced pulmonary fibrosis.Mice deficient in Chop were characterized by a reduced TGF-β production along with attenuated Smda2/3 signalling following BLM induction.Mechanistic studies showed that Chop deficiency enhanced the expression of SOCS1 and 3 and then repressed the activity of STAT6/PPAR-γ signalling to attenuate the M2 program in macrophages.Thereafter, the loss of Chop reduced the production of TGF-β.As a result, WT and Chop-/- mice manifested with a similar disease severity following BLM induction once macrophages were depleted or WT M2 macrophages were adoptively transferred into the lungs after depletion of endogenous macrophages.结论 These results not only provided novel insights into the understanding of IPF pathoaetiology but also provided evidence supporting that targeting Chop-related ER stress could be a viable strategy for the prevention and treatment of pulmonary fibrosis in clinical settings.
其他文献
目的 探讨多层螺旋CT[MSCT]引导下行肺部肿块穿刺活检的诊断价值.方法 在GE16排螺旋CT引导下,应用上海美创16及18G同轴引导穿刺活检针,对156例经影像检查为肺部疑似肿瘤病例患者行经皮肺穿刺活检.结果 156例经皮肺穿刺活检患者,病理结果为肺鳞癌81例、腺癌65例、恶性纤维组织细胞瘤1例、结核2例、炎性假瘤1例、炎性纤维增生2例、经二次穿刺确诊为腺癌l例、3例患者穿刺物诊断为炎性组织(
目的 To summarize the evidence of PFD for the treatment of IPF.To assess efficacy and adverse events, and provide relevant data on PFD for the treatment of IPF.方法 In this systematic review, we searched
目的 探讨结节病复发的主要临床特点及影响复发的因素 方法 对2008年-2014年我院门诊及住院经病理确诊为结节病的103例患者进行随访12-82个月,平均随访43.1±19.7个月,筛选出符合复发诊断标准的患者,将其临床特点与未复发的患者进行回顾性对比分析.结果(1)103例患者中自行缓解16例,87例患者行糖皮质激素治疗,其中复发22例(男性1例,女性21例),平均年龄50±8岁;I期2例,Ⅱ
目的 分析肺纤维化患者肝纤四项(LN、ⅣC、PⅢNP、HA)变化及临床意义.方法回顾性分析我院行肝纤四项检测的ILD323例,并随访观察. 结果 323例ILD中,IPF162例,CTD-ILD161例,正常对照160例.IPF和CTD-ILD组肝纤四项明显高于正常对照组.IPF和CTD-ILD组肝纤四项与肺功能FVC % pred、DLCO % pred负相关,与胸部HRCT评分正相关.IPF和
目的 探讨表现为间质性肺炎的肺血管内大B细胞淋巴瘤(肺IVLBCL)的临床特点、影像学特点及预后,以提高对该病的关注和认知.方法 对2例胸部HRCT表现为间质性肺炎的IVLBCL患者的临床、病理、影像学特点与转归情况,结合文献进行回顾性分析.并以“肺血管内淋巴瘤”为关键词在万方数据库、中国知网以及Pubmed数据库中检索相关文献,筛选大B细胞淋巴瘤的文献,分析其临床特点、肺部影像学特点以及预后.结
目的 Idiopathic Pulmonary Fibrosis(IPF) epidemiological studies analyzing have been done in south-western world,but few related studies have been carried out in China.Our study to determine prevalence r
目的 总结特发性肺纤维化(IPF)并发气胸的发病率、发病机制、临床表现、诊断、治疗及预后.方法 对1例IPF并发气胸患者成功治疗的临床资料进行分析,并回顾相关文献.结果 IPF并发气胸,临床上可表现为呼吸困难、咳嗽、胸痛,病情迅速恶化.IPF并发气胸行胸腔引流通常不能治愈,推荐胸腔镜手术治疗,一般不选用开胸手术,不能耐受手术可行胸腔闭式引流下胸腔内注入粘连剂治疗.IPF合并肺癌继发气胸常为难治性气
目的 Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and highly lethal fibrotic lung disease with unknown cause or cure.Although some microRNAs (miRNAs) have been confirmed the contributi
目的 观察盐酸氨溴索联合阿奇霉素治疗肺间质纤维化的临床疗效.方法 将40例IPF患者随机分为治疗组和对照组各20例.对照组给予强的松口服治疗,治疗组给予口服阿奇霉素和盐酸氨溴索缓释胶囊口服.两组疗程均为12月.比较两组临床疗效,治疗前后肺功能及血气分析指标的变化.结果 临床缓解率治疗组70%,对照组68.42%,两组比较无显著性差异,治疗组与对照组治疗前及治疗后动脉血氧分压PaO2及PaCO2相比
目的 探讨胆汁酸慢性吸入在肺纤维化发生发展的作用.方法 32只雌性SD大鼠分为对照组、鹅脱氧胆酸(CDCA)组、去氧胆酸(DCA)和石胆酸(LCA)组,每组8只.分别给予CDCA、LCA和DCA气管内注入(250 μmol/L,每周1次,每次0.5mL/Kg),对照组气管内注射生理盐水.造模第6周后处死大鼠,检测肺组织病理,测定纤维化标志物和细胞因子在肺组织中的表达.结果 CDCA、DCA和LCA